Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy — New York, New York

Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy?

Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy conducted?

Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Is Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy accredited by Crixeo Health?

Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.